Conning Inc. lessened its stake in Morgan Stanley (NYSE:MS – Free Report) by 22.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 290,356 shares of the financial services provider’s stock after selling 85,303 shares during the period. Morgan Stanley comprises approximately 1.3% of Conning Inc.’s portfolio, making the stock its 18th largest position. Conning Inc.’s holdings in Morgan Stanley were worth $36,504,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. grew its stake in shares of Morgan Stanley by 75.2% in the third quarter. Franklin Resources Inc. now owns 7,850,848 shares of the financial services provider’s stock valued at $881,493,000 after buying an additional 3,369,520 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Morgan Stanley by 382.4% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock valued at $166,555,000 after acquiring an additional 1,266,600 shares during the period. International Assets Investment Management LLC purchased a new position in Morgan Stanley during the 4th quarter valued at about $89,761,000. Fisher Asset Management LLC grew its position in Morgan Stanley by 2.7% in the 3rd quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider’s stock valued at $2,335,495,000 after acquiring an additional 590,872 shares in the last quarter. Finally, Strategic Financial Concepts LLC purchased a new stake in Morgan Stanley during the fourth quarter worth about $71,927,000. Hedge funds and other institutional investors own 84.19% of the company’s stock.
Morgan Stanley Stock Performance
Shares of MS stock opened at $139.88 on Friday. Morgan Stanley has a 1 year low of $83.09 and a 1 year high of $142.03. The company has a debt-to-equity ratio of 3.14, a quick ratio of 0.80 and a current ratio of 0.80. The firm has a market cap of $225.36 billion, a price-to-earnings ratio of 17.62, a PEG ratio of 1.22 and a beta of 1.37. The stock’s 50-day moving average is $130.51 and its two-hundred day moving average is $117.00.
Morgan Stanley Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 31st will be paid a dividend of $0.925 per share. This represents a $3.70 annualized dividend and a yield of 2.65%. The ex-dividend date is Friday, January 31st. Morgan Stanley’s dividend payout ratio is presently 46.60%.
Insider Buying and Selling at Morgan Stanley
In other news, insider Eric F. Grossman sold 13,097 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $136.20, for a total value of $1,783,811.40. Following the completion of the sale, the insider now directly owns 197,444 shares of the company’s stock, valued at $26,891,872.80. This trade represents a 6.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Raja Akram sold 17,500 shares of the company’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $136.01, for a total value of $2,380,175.00. Following the transaction, the chief financial officer now directly owns 81,440 shares in the company, valued at $11,076,654.40. This represents a 17.69 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the stock. Bank of America lifted their price objective on shares of Morgan Stanley from $146.00 to $153.00 and gave the company a “buy” rating in a report on Friday, January 17th. JPMorgan Chase & Co. boosted their price target on shares of Morgan Stanley from $104.00 to $108.00 and gave the stock a “neutral” rating in a research note on Monday, January 13th. HSBC lowered Morgan Stanley from a “buy” rating to a “hold” rating and lifted their target price for the company from $128.00 to $131.00 in a report on Tuesday, November 26th. Jefferies Financial Group upped their price target on Morgan Stanley from $120.00 to $135.00 and gave the stock a “buy” rating in a report on Thursday, October 17th. Finally, UBS Group lifted their price objective on Morgan Stanley from $130.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, January 21st. Eleven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, Morgan Stanley currently has a consensus rating of “Hold” and a consensus price target of $131.27.
Check Out Our Latest Stock Analysis on MS
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
See Also
- Five stocks we like better than Morgan Stanley
- Consumer Discretionary Stocks Explained
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Investors Need to Know to Beat the Market
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is the Dogs of the Dow Strategy? Overview and Examples
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.